Abstract
Neonatal group B streptococcal disease has become less common but still constitutes a major cause ofmorbidity andmortality. Around the world, a variety of preventive strategies are in place with varying degrees of implementation and success. This article reviews these approaches and looks to the future.
Original language | English |
---|---|
Pages (from-to) | e426-e429 |
Journal | NeoReviews |
Volume | 15 |
Issue number | 10 |
DOIs | |
State | Published - 1 Oct 2014 |
Bibliographical note
Publisher Copyright:© 2014 by the American Academy of Pediatrics. All rights reserved.